Drug & intervention
phentermine 3.75 MG / topiramate 23 MG [Qsymia]
RxCUI 1302841
What this record represents
SBDC · RxNormThis is an RxNorm SBDC drug concept. Its name, formulation details and source identifiers are preserved to distinguish it from other drug records.
What this record does not establish: current marketing availability, therapeutic equivalence, safety, or official approval status. Check an up-to-date product label or a pharmacist for product-specific questions.
Related drug records
RxNorm name matchesThese are other published drug concepts with matching brand or formulation names. They are not necessarily equivalent medicines.
QsymiaBN · CureCurrent ID 55732
phentermine 15 MG / topiramate 92 MG [Qsymia]SBDC · CureCurrent ID 53037
phentermine 7.5 MG / topiramate 46 MG [Qsymia]SBDC · CureCurrent ID 53026
phentermine 11.25 MG / topiramate 69 MG [Qsymia]SBDC · CureCurrent ID 54129
phentermine / topiramate Extended Release Oral Capsule [Qsymia]SBDF · CureCurrent ID 53027
24 HR phentermine 15 MG / topiramate 92 MG Extended Release Oral Capsule [Qsymia]SBD · CureCurrent ID 53038
24 HR phentermine 7.5 MG / topiramate 46 MG Extended Release Oral Capsule [Qsymia]SBD · CureCurrent ID 53028
24 HR phentermine 3.75 MG / topiramate 23 MG Extended Release Oral Capsule [Qsymia]SBD · CureCurrent ID 53033
24 HR phentermine 11.25 MG / topiramate 69 MG Extended Release Oral Capsule [Qsymia]SBD · CureCurrent ID 54130
Advertisement
Active ingredients and chemical structures
RxNorm ingredient relationships. Structures are retrieved by PubChem compound identifier when available. An ingredient can have both a base and a precise salt concept.
Conditions being studied
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.